[HTML][HTML] Efficacy of resveratrol supplementation against non-alcoholic fatty liver disease: a meta-analysis of placebo-controlled clinical trials
C Zhang, W Yuan, J Fang, W Wang, P He, J Lei… - PLoS …, 2016 - journals.plos.org
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease with
rising prevalence. Increasing evidence has demonstrated that resveratrol, a dietary …
rising prevalence. Increasing evidence has demonstrated that resveratrol, a dietary …
Efficacy of Resveratrol Supplementation against Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Placebo-Controlled Clinical Trials
C Zhang, W Yuan, J Fang, W Wang, P He, J Lei… - PLOS ONE, 2016 - ideas.repec.org
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease with
rising prevalence. Increasing evidence has demonstrated that resveratrol, a dietary …
rising prevalence. Increasing evidence has demonstrated that resveratrol, a dietary …
[引用][C] Efficacy of Resveratrol Supplementation against Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Placebo-Controlled Clinical Trials
C Zhang, W Yuan, J Fang, W Wang, P He, J Lei… - PLoS …, 2016 - ui.adsabs.harvard.edu
Efficacy of Resveratrol Supplementation against Non-Alcoholic Fatty Liver Disease: A Meta-Analysis
of Placebo-Controlled Clinical Trials - NASA/ADS Now on home page ads icon ads Enable full …
of Placebo-Controlled Clinical Trials - NASA/ADS Now on home page ads icon ads Enable full …
[HTML][HTML] Efficacy of Resveratrol Supplementation against Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Placebo-Controlled Clinical Trials
C Zhang, W Yuan, J Fang, W Wang, P He, J Lei… - PLoS ONE, 2016 - ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease with
rising prevalence. Increasing evidence has demonstrated that resveratrol, a dietary …
rising prevalence. Increasing evidence has demonstrated that resveratrol, a dietary …
Efficacy of Resveratrol Supplementation against Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Placebo-Controlled Clinical Trials
C Zhang, W Yuan, J Fang, W Wang, P He, J Lei… - PloS …, 2016 - pubmed.ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease with
rising prevalence. Increasing evidence has demonstrated that resveratrol, a dietary …
rising prevalence. Increasing evidence has demonstrated that resveratrol, a dietary …
Efficacy of Resveratrol Supplementation against Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Placebo-Controlled Clinical Trials
C Zhang, W Yuan, J Fang, W Wang, P He, J Lei… - PLoS ONE, 2016 - go.gale.com
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease with
rising prevalence. Increasing evidence has demonstrated that resveratrol, a dietary …
rising prevalence. Increasing evidence has demonstrated that resveratrol, a dietary …
Efficacy of Resveratrol Supplementation against Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Placebo-Controlled Clinical Trials.
C Zhang, W Yuan, J Fang, W Wang, P He, J Lei… - PLoS …, 2016 - search.ebscohost.com
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease with
rising prevalence. Increasing evidence has demonstrated that resveratrol, a dietary …
rising prevalence. Increasing evidence has demonstrated that resveratrol, a dietary …
Efficacy of Resveratrol Supplementation against Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Placebo-Controlled Clinical Trials.
C Zhang, W Yuan, J Fang, W Wang, P He, J Lei… - Plos one, 2016 - europepmc.org
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease with
rising prevalence. Increasing evidence has demonstrated that resveratrol, a dietary …
rising prevalence. Increasing evidence has demonstrated that resveratrol, a dietary …
Efficacy of Resveratrol Supplementation against Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Placebo-Controlled Clinical Trials
C Zhang, W Yuan, J Fang, W Wang, P He, J Lei… - PLOS …, 2016 - econpapers.repec.org
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease with
rising prevalence. Increasing evidence has demonstrated that resveratrol, a dietary …
rising prevalence. Increasing evidence has demonstrated that resveratrol, a dietary …
[PDF][PDF] Efficacy of Resveratrol Supplementation against Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Placebo-Controlled Clinical Trials
C Zhang, W Yuan, J Fang, W Wang, P He… - PLoS …, 2016 - pdfs.semanticscholar.org
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease with
rising prevalence. Increasing evidence has demonstrated that resveratrol, a dietary …
rising prevalence. Increasing evidence has demonstrated that resveratrol, a dietary …